درباره این اپیزود
Sep 7, 2026 – Boston College’s Dr. Thomas Seyfried tells Financial Sense Newshour’s Jim Puplava why he believes cancer is a mitochondrial metabolic disease—not primarily a genetic one. He explains why conventional treatments may miss the real driver...
انگلیسی
ایالات متحده آمریکا
رونوشت 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
جستجوی اپیزودهای گذشته
اپیزودهای قبلی Financial Sense Newshour را جستجو کن.
قسمت های دیگر در این پادکست
Oct 8, 2026 – Bond yields are back to levels not seen since 2002, and Greg Weldon says the chaos is only beginning. Jim Puplava sits down with the veteran trader and author of Gold Trading Boot Camp to unpack a world under pressure from every angle...
Oct 7, 2026 – Is Greenland the blueprint for a new American geopolitical strategy? Edward Gustely joins FS Insider's Cris Sheridan to explore how strategic access strengthens U.S. positioning in the Arctic and counter China’s influence...
Oct 5, 2026 – What does it take for a family business to survive beyond the founder? Brendan McMurtrie and Ryan Puplava explore the essential challenges of business succession planning, using the Anheuser-Busch sale as a compelling case study of...
Oct 9, 2026 – There's a disagreement developing in the markets that I think investors need to pay attention to, particularly if they've benefited from the tremendous rally in artificial intelligence stocks. Credit markets are becoming increasingly concerned...
Oct 9, 2026 – The S&P 500 keeps hitting new highs while most of its stocks quietly crash. Jim Puplava sits down with Jeffrey Huge, chief investment officer at JWH Investment Partners, to unpack a market that is overconcentrated, overvalued, overleveraged, and over-owned...
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به Financial Sense است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
